Name | Number of supported studies | Average coverage | |
---|---|---|---|
smooth muscle cell | 10 studies | 23% ± 4% | |
endothelial cell | 9 studies | 20% ± 5% | |
pericyte | 8 studies | 18% ± 3% | |
cardiac muscle cell | 5 studies | 22% ± 3% | |
basal cell | 5 studies | 19% ± 2% | |
myofibroblast cell | 4 studies | 22% ± 5% | |
capillary endothelial cell | 4 studies | 17% ± 2% | |
fibroblast | 4 studies | 19% ± 3% | |
type I pneumocyte | 4 studies | 21% ± 5% | |
epithelial cell | 3 studies | 32% ± 8% |
Insufficient scRNA-seq data for expression of DAPK3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5814.27 | 1445 / 1445 | 100% | 38.37 | 183 / 183 |
uterus | 100% | 6315.09 | 170 / 170 | 100% | 64.00 | 458 / 459 |
skin | 100% | 3780.83 | 1808 / 1809 | 100% | 59.96 | 471 / 472 |
intestine | 100% | 5582.76 | 966 / 966 | 99% | 47.27 | 524 / 527 |
breast | 100% | 3817.67 | 459 / 459 | 99% | 55.23 | 1111 / 1118 |
thymus | 100% | 2668.45 | 651 / 653 | 100% | 36.88 | 603 / 605 |
stomach | 100% | 3984.79 | 359 / 359 | 99% | 45.27 | 284 / 286 |
prostate | 100% | 5175.52 | 244 / 245 | 99% | 56.23 | 499 / 502 |
bladder | 100% | 4878.76 | 21 / 21 | 99% | 52.60 | 497 / 504 |
lung | 100% | 5591.20 | 576 / 578 | 99% | 43.62 | 1140 / 1155 |
adrenal gland | 100% | 2069.43 | 257 / 258 | 99% | 44.62 | 227 / 230 |
ovary | 100% | 3718.58 | 180 / 180 | 98% | 25.68 | 422 / 430 |
kidney | 99% | 2189.08 | 88 / 89 | 99% | 35.49 | 891 / 901 |
pancreas | 97% | 1655.80 | 317 / 328 | 100% | 62.49 | 178 / 178 |
brain | 96% | 2295.61 | 2535 / 2642 | 100% | 62.89 | 705 / 705 |
liver | 89% | 1390.71 | 202 / 226 | 99% | 35.04 | 401 / 406 |
eye | 0% | 0 | 0 / 0 | 100% | 57.86 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 51.38 | 29 / 29 |
muscle | 100% | 4944.63 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2539.85 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 54.70 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 65.27 | 1 / 1 |
blood vessel | 100% | 6824.50 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 3670.47 | 1202 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 5587.41 | 852 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 1804.36 | 860 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0097190 | Biological process | apoptotic signaling pathway |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0006940 | Biological process | regulation of smooth muscle contraction |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0010506 | Biological process | regulation of autophagy |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0007346 | Biological process | regulation of mitotic cell cycle |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_2000145 | Biological process | regulation of cell motility |
GO_0043519 | Biological process | regulation of myosin II filament organization |
GO_0051893 | Biological process | regulation of focal adhesion assembly |
GO_0006915 | Biological process | apoptotic process |
GO_0008360 | Biological process | regulation of cell shape |
GO_0006468 | Biological process | protein phosphorylation |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0032956 | Biological process | regulation of actin cytoskeleton organization |
GO_0017148 | Biological process | negative regulation of translation |
GO_0007088 | Biological process | regulation of mitotic nuclear division |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0016605 | Cellular component | PML body |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0043522 | Molecular function | leucine zipper domain binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0031267 | Molecular function | small GTPase binding |
GO_0005524 | Molecular function | ATP binding |
GO_0008140 | Molecular function | cAMP response element binding protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | DAPK3 |
Protein name | Death associated protein kinase 3 Death-associated protein kinase 3 (DAP kinase 3) (EC 2.7.11.1) (DAP-like kinase) (Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase) (ZIP-kinase) |
Synonyms | ZIPK |
Description | FUNCTION: Serine/threonine kinase which is involved in the regulation of apoptosis, autophagy, transcription, translation and actin cytoskeleton reorganization. Involved in the regulation of smooth muscle contraction. Regulates both type I (caspase-dependent) apoptotic and type II (caspase-independent) autophagic cell deaths signal, depending on the cellular setting. Involved in regulation of starvation-induced autophagy. Regulates myosin phosphorylation in both smooth muscle and non-muscle cells. In smooth muscle, regulates myosin either directly by phosphorylating MYL12B and MYL9 or through inhibition of smooth muscle myosin phosphatase (SMPP1M) via phosphorylation of PPP1R12A; the inhibition of SMPP1M functions to enhance muscle responsiveness to Ca(2+) and promote a contractile state. Phosphorylates MYL12B in non-muscle cells leading to reorganization of actin cytoskeleton. Isoform 2 can phosphorylate myosin, PPP1R12A and MYL12B. Overexpression leads to condensation of actin stress fibers into thick bundles. Involved in actin filament focal adhesion dynamics. The function in both reorganization of actin cytoskeleton and focal adhesion dissolution is modulated by RhoD. Positively regulates canonical Wnt/beta-catenin signaling through interaction with NLK and TCF7L2. Phosphorylates RPL13A on 'Ser-77' upon interferon-gamma activation which is causing RPL13A release from the ribosome, RPL13A association with the GAIT complex and its subsequent involvement in transcript-selective translation inhibition. Enhances transcription from AR-responsive promoters in a hormone- and kinase-dependent manner. Involved in regulation of cell cycle progression and cell proliferation. May be a tumor suppressor. . |
Accessions | ENST00000601824.1 ENST00000594894.1 M0QYY8 M0QYW5 ENST00000545797.7 [O43293-1] M0R0D0 ENST00000596311.5 O43293 ENST00000593844.1 ENST00000301264.7 [O43293-1] |